Sarah P. Young

Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants

Priya S. Kishnani, Paula Goldenberg, Stephanie DeArmey et al. · Molecular Genetics and Metabolism · 2009 · 372 citations

Vaccination, Clinical Immunology, Autoimmune Disease +10

BMP9 Mutations Cause a Vascular-Anomaly Syndrome with Phenotypic Overlap with Hereditary Hemorrhagic Telangiectasia

Whitney Wooderchak‐Donahue, Jamie McDonald, Brendan O’Fallon et al. · The American Journal of Human Genetics · 2013 · 302 citations · Full text

Vascular-anomaly Syndrome, Mendelian Disorder, Hereditary Hemorrhagic Telangiectasia +11

Successful immune tolerance induction to enzyme replacement therapy in CRIM-negative infantile Pompe disease

Yoav H. Messinger, Nancy J. Mendelsohn, William J. Rhead et al. · Genetics in Medicine · 2012 · 209 citations · Full text

Primary Immunodeficiency, Maternal Immunization, Autoimmune Disease +12

Interaction between <i>alk1</i> and blood flow in the development of arteriovenous malformations

Paola Corti, Sarah P. Young, Chia‐Yuan Chen et al. · Development · 2011 · 206 citations

Vascular Disease, Vascular Malformation, Cellular Physiology +22

The emerging phenotype of long-term survivors with infantile Pompe disease

Sean N. Prater, Suhrad G. Banugaria, Stephanie DeArmey et al. · Genetics in Medicine · 2012 · 187 citations · Full text

Infantile Pompe Disease, Pathogenesis, Genetic Epidemiology +3